LH vs SENS: fair value comparison
Labcorp Holdings Inc. and Senseonics Holdings, Inc. · Updated 2026-10-19
SENS has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, LH currently ranks higher by quality score.
| LH | SENS | |
|---|---|---|
| Verdict | Fairly valued | No estimate yet |
| Last price | $312.15 | $7.77 |
| 12-month range | $246.64–$339.34 | $4.86–$10.34 |
| Rank by discount to fair value | #69 of 108 Healthcare | — |
| Rank by quality score | #136 of 301 Healthcare | #138 of 301 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: LH fair value analysis · SENS fair value analysis